{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:49:50Z","timestamp":1790952590170,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000101","name":"Pierre Elliott Trudeau Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Psychology Review"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cpr.2020.101939","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T21:44:44Z","timestamp":1603489484000},"page":"101939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review"],"prefix":"10.1016","volume":"82","author":[{"given":"Stephanie","family":"Lake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"St. Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpr.2020.101939_bb0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08897077.2015.1065541","article-title":"Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study","volume":"37","author":"Abrahamsson","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.cpr.2020.101939_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13722-015-0034-5","article-title":"Factors associated with willingness to take extended release naltrexone among injection drug users","volume":"10","author":"Ahamad","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.cpr.2020.101939_bb0015","author":"ASAM"},{"key":"10.1016\/j.cpr.2020.101939_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000406","article-title":"Does cannabis use influence opioid outcomes and quality of life among buprenorphine maintained patients? A cross-sectional, comparative study","volume":"12","author":"Bagra","year":"2018","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.cpr.2020.101939_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13293-015-0038-6","article-title":"Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: A multicenter cohort study","volume":"6","author":"Bawor","year":"2015","journal-title":"Biology of Sex Differences"},{"key":"10.1016\/j.cpr.2020.101939_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.cpr.2020.101939_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/09595239996734","article-title":"Cannabis use in relation to illicit drug use and health problems among opiate misusers in treatment","volume":"18","author":"Best","year":"1999","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.cpr.2020.101939_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09595230096093","article-title":"Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment","volume":"19","author":"Best","year":"2000","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.cpr.2020.101939_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","article-title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","volume":"154","author":"Bisaga","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0050","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: A national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.cpr.2020.101939_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1360-0443.1998.9344935.x","article-title":"Marijuana use and treatment outcome among opioid-dependent patients","volume":"93","author":"Budney","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0060","author":"Centre for Addiction and Mental Health"},{"key":"10.1016\/j.cpr.2020.101939_bb0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1192\/pb.bp.111.035063","article-title":"Predictors for retention in treatment with a UK community-based naltrexone programme for opioid dependence","volume":"36","author":"Chaudhry","year":"2012","journal-title":"Psychiatrist"},{"key":"10.1016\/j.cpr.2020.101939_bb0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1081\/ADA-100104511","article-title":"Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence","volume":"27","author":"Church","year":"2001","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.cpr.2020.101939_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/14659891.2015.1021867","article-title":"An open label naturalistic study of predictors of retention and compliance to naltrexone maintenance treatment among patients with opioid dependence","volume":"21","author":"Dayal","year":"2016","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.cpr.2020.101939_bb0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: A systematic analysis for the global burden of disease study 2016","volume":"5","author":"Degenhardt","year":"2018","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.cpr.2020.101939_bb0085","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global burden of disease attributable to illicit drug use and dependence: Findings from the global burden of disease study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.cpr.2020.101939_bb0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.drugalcdep.2018.11.008","article-title":"Change in alcohol and other drug use during five years of continuous opioid substitution treatment","volume":"194","author":"Eastwood","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0095","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1037\/0022-006X.45.4.709","article-title":"Marijuana use by heroin abusers as a factor in program retention","volume":"45","author":"Ellner","year":"1977","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.cpr.2020.101939_bb0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","article-title":"Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against","volume":"98","author":"Epstein","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/ajad.12183","article-title":"No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper","volume":"24","author":"Epstein","year":"2015","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.cpr.2020.101939_bb0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/00952999309001635","article-title":"Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up","volume":"19","author":"Fairbank","year":"1993","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.cpr.2020.101939_bb0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/ADM.0000000000000057","article-title":"Factors affecting noncompliance with buprenorphine maintenance treatment","volume":"8","author":"Fareed","year":"2014","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.cpr.2020.101939_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2013.10.011","article-title":"Changes in quality of life (WHOQOL-Bref) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review","volume":"134","author":"Feelemyer","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187633","article-title":"The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada","volume":"12","author":"Franklyn","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cpr.2020.101939_bb0130","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/add.14842","article-title":"\u201cStandard THC units\u201d: A proposal to standardize dose across all cannabis products and methods of administration","volume":"115","author":"Freeman","year":"2020","journal-title":"Addiction."},{"key":"10.1016\/j.cpr.2020.101939_bb0135","series-title":"Marihuana reconsidered","author":"Grinspoon","year":"1971"},{"key":"10.1016\/j.cpr.2020.101939_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2016\/6487217","article-title":"Correlates of nine-month retention following interim buprenorphine-naloxone treatment in opioid dependence: A pilot study","volume":"2016","author":"H\u00e5kansson","year":"2016","journal-title":"Journal of Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.drugalcdep.2013.02.030","article-title":"Association of cannabis use with opioid outcomes among opioid-dependent youth","volume":"132","author":"Hill","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0155","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2020.101939_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2017.04.012","article-title":"Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults","volume":"85","author":"Jarvis","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.cpr.2020.101939_bb0165","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1360-0443.1998.93811776.x","article-title":"Effects of readiness for drug abuse treatment on client retention and assessment of process","volume":"93","author":"Joe","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.drugalcdep.2018.01.027","article-title":"Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada","volume":"186","author":"Klimas","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233463","article-title":"Characterizing motivations for cannabis use in a cohort of people who use illicit drugs: A latent class analysis","volume":"15","author":"Lake","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cpr.2020.101939_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002967","article-title":"Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis","volume":"16","author":"Lake","year":"2019","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.cpr.2020.101939_bb0185","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/add.12970","article-title":"Dose-response relationship between methadone dose and adherence to antiretroviral therapy among hiv-positive people who use illicit opioids","volume":"110","author":"Lappalainen","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2015.01.009","article-title":"Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment","volume":"54","author":"Levine","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.cpr.2020.101939_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2013.10.018","article-title":"Predictors of non-prescribed opioid use after one year of methadone treatment: An attributable-risk approach (ANRS-Methaville trial)","volume":"135","author":"Lions","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12954-017-0183-9","article-title":"Rationale for cannabis-based interventions in the opioid overdose crisis","volume":"14","author":"Lucas","year":"2017","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.cpr.2020.101939_bb0205","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/ADM.0000000000000035","article-title":"A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine\/naloxone clinic","volume":"8","author":"Matson","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.cpr.2020.101939_bb0210","first-page":"(Cd002209)","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.cpr.2020.101939_bb0215","article-title":"Cannabis use during methadone maintenance treatment for opioid use disorder: A systematic review and meta-analysis","volume":"7","author":"McBrien","year":"2019","journal-title":"Canadian Medical Association Journal Open"},{"key":"10.1016\/j.cpr.2020.101939_bb0220","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/10826084.2017.1342662","article-title":"Medication-assisted treatment for opioid addiction in the United States: Critique and commentary","volume":"53","author":"McElrath","year":"2018","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.cpr.2020.101939_bb0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.cpr.2020.101939_bb0230","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.pnpbp.2007.03.013","article-title":"Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts","volume":"31","author":"Nava","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.cpr.2020.101939_bb0235","unstructured":"NIH NHLBI. Quality assessment tools. Accessed 2019 September 19 from https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools, n.d."},{"key":"10.1016\/j.cpr.2020.101939_bb0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1037\/0893-164X.10.4.222","article-title":"Cannabis versus other illicit drug use among methadone maintenance patients","volume":"10","author":"Nirenberg","year":"1996","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.cpr.2020.101939_bb0245","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amepre.2006.08.017","article-title":"Opioid analgesics and rates of fatal drug poisoning in the United States","volume":"31","author":"Paulozzi","year":"2006","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.cpr.2020.101939_bb0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10550880802324382","article-title":"One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel","volume":"27","author":"Peles","year":"2008","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.cpr.2020.101939_bb0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.09.004","article-title":"Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel","volume":"82","author":"Peles","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2017.11.034","article-title":"Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (mmt) center","volume":"185","author":"Peles","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0265","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.cpr.2020.101939_bb0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","article-title":"Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from starting treatment with agonist replacement therapies (start)","volume":"74","author":"Potter","year":"2013","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.cpr.2020.101939_bb0275","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/14659891.2015.1118564","article-title":"Outcome predictors for patients receiving methadone maintenance treatment: Findings from a retrospective multi-site study","volume":"21","author":"Proctor","year":"2016","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.cpr.2020.101939_bb0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10550490902927785","article-title":"Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence","volume":"18","author":"Raby","year":"2009","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.cpr.2020.101939_bb0285","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/add.14238","article-title":"Cannabis and opioid overdoses: Time to move on and examine potential mechanisms","volume":"113","author":"Rogeberg","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0290","first-page":"8","article-title":"Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: The need for a more comprehensive approach","author":"Roux","year":"2011","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.cpr.2020.101939_bb0295","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.2174\/13816128113199990623","article-title":"Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: Implications for clinicians","volume":"20","author":"Roux","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.cpr.2020.101939_bb0300","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.cpr.2020.101939_bb0305","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3389\/fpls.2018.01969","article-title":"The case for the entourage effect and conventional breeding of clinical cannabis: No \u201cstrain,\u201d no gain","volume":"9","author":"Russo","year":"2018","journal-title":"Frontiers in Plant Science"},{"key":"10.1016\/j.cpr.2020.101939_bb0310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apha.2017.03.004","article-title":"Cannabis pharmacology: The usual suspects and a few promising leads","volume":"80","author":"Russo","year":"2017","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/j.cpr.2020.101939_bb0315","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1360-0443.1996.918119711.x","article-title":"Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome","volume":"91","author":"Saxon","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0320","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1521-0391.2013.12044.x","article-title":"Impact of cannabis use during stabilization on methadone maintenance treatment","volume":"22","author":"Scavone","year":"2013","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.cpr.2020.101939_bb0325","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1521-0391.2012.00226.x","article-title":"Impact of an 18-month, nhs-based, treatment exposure for heroin dependence: Results from the London area treat 2000 study","volume":"21","author":"Schifano","year":"2012","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.cpr.2020.101939_bb0330","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.addbeh.2007.01.010","article-title":"Retention and illicit drug use among methadone patients in Israel: A gender comparison","volume":"32","author":"Schiff","year":"2007","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.cpr.2020.101939_bb0335","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.cpr.2020.101939_bb0340","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2019.78","article-title":"The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment","volume":"5","author":"Shams","year":"2019","journal-title":"BJPsych Open"},{"key":"10.1016\/j.cpr.2020.101939_bb0345","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/add.14398","article-title":"High-intensity cannabis use is associated with retention in opioid agonist treatment: A longitudinal analysis","volume":"113","author":"Soc\u00edas","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.cpr.2020.101939_bb0350","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","article-title":"Pharmacological and behavioral treatment of opioid use disorder","volume":"1","author":"Sofuoglu","year":"2019","journal-title":"Psychiatric Research and Clinical Practice"},{"key":"10.1016\/j.cpr.2020.101939_bb0355","first-page":"295","article-title":"Retrospective study of outcomes, for patients admitted to a drug treatment Centre board","volume":"105","author":"Somers","year":"2012","journal-title":"Irish Medical Journal"},{"key":"10.1016\/j.cpr.2020.101939_bb0360","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"British Medical Journal"},{"key":"10.1016\/j.cpr.2020.101939_bb0365","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.cpr.2020.101939_bb0370","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0028-3908(95)00032-2","article-title":"Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine","volume":"34","author":"Vela","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cpr.2020.101939_bb0375","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","article-title":"Predictors of retention in methadone programs: A signal detection analysis","volume":"83","author":"Villafranca","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0380","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(98)00092-1","article-title":"Factors associated with lapses to heroin use during methadone maintenance","volume":"52","author":"Wasserman","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.cpr.2020.101939_bb0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1440-1614.2003.01296.x","article-title":"Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: A 1-year prospective study in an Israeli clinic","volume":"38","author":"Weizman","year":"2004","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2020.101939_bb0390","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/02791072.2014.901587","article-title":"Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention","volume":"46","author":"White","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.cpr.2020.101939_bb0395","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(01)02655-5","article-title":"Endogenous cannabinoid, 2-Arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice","volume":"909","author":"Yamaguchi","year":"2001","journal-title":"Brain Research"},{"key":"10.1016\/j.cpr.2020.101939_bb0400","doi-asserted-by":"crossref","DOI":"10.1186\/s13293-017-0130-1","article-title":"Association between cannabis use and methadone maintenance treatment outcomes: An investigation into sex differences","volume":"8","author":"Zielinski","year":"2017","journal-title":"Biology of Sex Differences"}],"container-title":["Clinical Psychology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735820301276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735820301276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:35:47Z","timestamp":1759466147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272735820301276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":80,"alternative-id":["S0272735820301276"],"URL":"https:\/\/doi.org\/10.1016\/j.cpr.2020.101939","relation":{},"ISSN":["0272-7358"],"issn-type":[{"value":"0272-7358","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Psychology Review","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpr.2020.101939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101939"}}